Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC)

Clinical trial NCT04930549 · COMPLETED

Trial details

NCT number: NCT04930549
Sponsor: University Hospital, Rouen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic

Start date: 2022-10-18
Primary completion: 2024-09-23
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.